Dossier status
The STPP REACH consortium has now completed and submitted the STPP REACH Registration Dossier (IUCLID5 file and CSR Dossier) and submitted to ECHA on 8/2/2010 under joint submission name "Pentasodium Triphosphate_JS". The dossier has been accepted as complete. Technical work was done by Safepharm / Harlan, UK, and the Lead Company is FMC Foret.

The submitted dossier includes a Testing Proposal for a 90-day inhalation toxicity study in rats, but the Consortium considers that this study is not justified taking into account the requirements of REACH to minimise animal testing and for the reasons indicated in the attached document. This proposal has been submitted to public consultation by ECHA on 8th April 2010 at http://echa.europa.eu/consultations/test_proposals/test_prop_cons_en.asp

• Testing proposal argument

Summary of the submitted IUCLID and CSR as submitted are available here (pending publication of the IUCLID dossier by ECHA as per the REACH Regulation), as well as a full list of all studies relevant to this substance identified by the Consortium.

• STPP IUCLID summary
• STPP CSR summary
• STPP studies list
• STPP list of uses as submitted (extract of submitted CSR)
• STPP proposed revised list of uses (IUCLID 5.2 format)